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Objective: To study the therapeutic mechanisms of pseudolaric acid on allergic contact
dermatitis in mice.
Methods: A total of 50 BALB/C mice were selected and randomly divided into control
group, model group, and treatment A, B, C groups with 10 rats in each group. ACD model
was established inmodel group, and treatmentA,B,C groups but not in control group.Model
group received no treatment, but treatment A, B, C groups were treated with external
application of the concentration of 0.1%, 0.2% and 0.4% of the pseudolaric acid for the le-
sions of ear skin. And the weight gain and the swelling degree of themice' ear were recorded,
weight of thymus and spleen were measured. Spleen suspension was prepared to test T
lymphocyte and B lymphocyte levels of mice in ﬁve groups. Changes in serum IFN-g, IL-4
and IL-10 levels were tested through the enzyme linked immunosorbent assay (ELISA).
Results: The weight gain of mice in model group were signiﬁcant lower than those of
mice in the control group and the treatment A, B, C groups (P < 0.05). Weight gain of
mice in treatment A, B groups were signiﬁcant lower than that of control group
(P < 0.05), but the difference in weight gain between treatment C group and control
group showed no signiﬁcant difference (P > 0.05). The swelling degree and the weight of
mice ears in model group were signiﬁcant higher than those of mice in control group and
treatment A, B, C groups (P < 0.05). Swelling degree and the weight of mice ears of
treatment A, B, C groups were obviously higher than that of control group (P < 0.05).
The swelling degree and weight of mice' ears in treatment A, B, C groups were decreased
with the increase of the drug dosage, but comparison between A, B and C group showed
statistically differences (P < 0.05). The thymus and spleen index of mice in model group
were signiﬁcant higher than those of the other four groups (P < 0.05), among the four
groups, thymus and spleen index of treatment A and B group were higher than control
group and treatment C group (P < 0.05). The stimulation index of T and B cells of mice
in model group was signiﬁcantly higher than the rest four groups (P < 0.05). The serum
IFN-g level of mice in control group and treatment A, B and C group was obviously
lower than that of mice in model group (P < 0.05). The serum IFN-g level of mice in
treatment A, B and C group were decreased with the increasing of the drug dosage, and
the level of C group was obviously lower than that of A and B group (P < 0.05).
Conclusion: The pseudolaric acid has anti-inﬂammation and immune adjustment the
effects showing a remarkable therapeutic effects for the ACD mice.Allergic contact dermatitis (ACD) is the skin inﬂammatory1. Introduction
disease caused by skin exposure with allergic source of external
environmental, which presents as the symptoms of erythema,
papula, edema, blister and even necrosis with different degree of
ache, pruritus or burning sensation [1–3]. The allergic contact
dermatitis can be induced by many different sensitizers, but
most of them are the chemicals of low molecular weight,
which can form the antigenic substance of high molecular
weight by combined with the epidermal protein [4]. A periodicle under the CC BY-NC-ND license (http://
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called latent period, and the organism of patients is in the
allergic state during this period, and the patients will suffer the
ACD within 48 h if they get in touch with the allergic source
again [5]. Studies have shown that [6] ACD is the allergic
reaction mediated by T-cell, the immune cells and the
cytokines, chemotactic factors and inﬂammatory mediators that
secreted by immune cells have the key effect on the
occurrence of ACD. In the clinical treatment, the patients
should be initially kept away from the allergic source, and
treated with the antihistamine drugs, non-steroidal anti-inﬂam-
matory drugs and the hormone drugs. However, sometimes it is
impossible to avoid the allergic sources completely, and the
antihistamine drugs and the hormone drugs could not cure ACD,
hence the ACD could severely inﬂuence patients' life quality [7].
Pseudolaric acid is the new diterpenoid acid chemical
compounds extracted from dry bark of pseudolarix raempferi
gordon, which can be used to treat the tinea, and has the
effect of insecticidal and anti-itch effects [8]. A research has
conﬁrmed that [9] pseudolaric acid has the prominent effects
on ACD. The BALB/C mice were selected to establish the
ACD model in this study in order to observe the immune
adjustment and the treatment effect of the pseudolaric acid on
the ACD mice, and the intervention treatment of pseudolaric
acid was given to observe its treatment effects and mechanism
of action on the ACD mice, which aimed at providing the
theoretical basis for the clinical application.
2. Materials and methods
2.1. Experimental animal
A total of 50 SPF grade, BALB/C male mice with ages of
12 weeks and body weight of 18–22 g were selected for the
experiment and the mice were provided by the Laboratory
Animal Centre of our hospital. The mice were feed freely in
the room temperature of (23 ± 3)C. In the process of the
experiment, the handling of animals was strictly abided by the
Regulation of Experimental Animals, and approved Ethics
Committee of Henan University. This experiment was oper-
ated and ﬁnished at the Experiment Center of Henan
University.
2.2. Medicines and instruments
The pseudolaric acid was purchased from Chengdu Biopurify
Phytochemicals Ltd., which was made by emulsiﬁable paste to
the ointment of the depthness of 0.1%, 0.2% and 0.4%. The
dinitroﬂuorobenzene (DNFB) was purchased from Shanghai
Shifeng Biological Technology Co., Ltd. The Compound
Dexamethasone Acetate Cream was produced by Sanjiu Phar-
maceutical Co., Ltd., the dexamethasone sodium phosphate in-
jection was produced by Tianjin Jinyao Amino Acid Co., Ltd.,
and the ciclosporin was purchased by North China Pharma-
ceutical Group Corporation Veterinary Co., Ltd. The TS100
type inverted microscope was purchased by Ni Kon Ltd., the
biological spectrophotometric meter was purchased by Germany
Eppendorf Ltd., the MCO-AC carbon dioxide cell incubator was
manufactured by SANYO Electrical Co., Ltd., and the C-
4040ZOOM optical microscope was manufactured by Shanghai
Ailang Instrument Co., Ltd., the ELISA reader was manufac-
tured by BIO-RAD Co., Ltd.2.3. Model establishing method
The dinitroﬂuorobenzene was used to establish the ACD
mice model. Method: the 8% of sodium sulﬁde was used to
remove the fur of the ﬁxed position of the rat's abdomen1 day
before establishing the model, which was (2 × 20) cm. And the
1% of 30 mL dinitroﬂuorobenzene was applied on the fur
removal part on the ﬁrst and the second day of establishing
model. The fur of the mice back was removed on the sixth day of
establishing model, and 5% of 30 mL dinitroﬂuorobenzene was
applied for stimulation, then 24 h later the model was prepared
successfully.
2.4. Grouping and treatment
A total of 50 BALB/C mice were randomly divided into
control group, model group, treatment A, B and C group with 10
rats in each group. ACD model in the rest 4 groups was induced
by the dinitrochlorobenzene (DNCB), but model was not
established in control group. Model group received no treatment,
the treatment A, B and C group were treated with external
application of the concentration of 0.1%, 0.2% and 0.4% of the
pseudolaric acid for the lesions of ear skin for twice a day.
2.5. Observational index
The weight gain and the swelling degree of the mice' ear were
recorded after the ﬁrst stimulating, and then the mice were
executed at the 8th day of establishing model to test the weight
of mice' ears, then the weight of thymus and spleen was
measured and their data indexes were calculated. And the spleen
suspension was prepared to test T lymphocyte and B lympho-
cyte levels of mice in ﬁve groups. Then the ophthalmic venous
plexus blood of mice in ﬁve groups was extracted, and the
changes of the serum IFN-g, IL-4 and IL-10 levels were tested
through the enzyme linked immunosorbent assay (ELISA).
2.6. Statistical analysis
The SPSS 13.0 software was used for data processing, the
experimental data was expressed as mean ± SD, and the one-
way analysis of variance was used for the comparison among
groups, P < 0.05 was statistically different.
3. Results
3.1. Comparison of weight gain, swelling degree of ear
and weight of ear of mice among ﬁve groups
The weight gain of mice in model group was signiﬁcant
lower than that of mice in control group and treatment A, B and
C group (P < 0.05), and weight gain of mice in treatment A and
B group were signiﬁcant lower than that in the control group
(P < 0.05). The comparison of weight gain of mice in treatment
C group and control group showed no signiﬁcant differences
(P > 0.05). The swelling degree of ear and weight of ear of mice
in model group were signiﬁcant higher than those of mice in
control group and treatment A, B and C group (P < 0.05), and
the swelling degree of ear and weight of ear of treatment A, B
and C group were signiﬁcant higher than that of the control
group (P < 0.05). The swelling degree of ear and weight of ear
Table 1
Comparison of weight gain, swelling degree of ear and weight of ear of
mice in ﬁve groups (n = 10).
Groups Weight
increment (g)
Swelling degree
of ear (mm)
Quality of
ear (mg)
Control group 1.63 ± 0.14# 0.005 ± 0.010# 0.81 ± 0.40#
Model group 1.04 ± 0.12* 0.330 ± 0.043* 14.91 ± 5.36*
Treatment A group 1.11 ± 0.12*# 0.231 ± 0.046*# 12.12 ± 4.25*#
Treatment B group 1.20 ± 0.13*# 0.180 ± 0.040*# 9.31 ± 1.82*#
Treatment C group 1.64 ± 0.15# 0.151 ± 0.031*# 6.66 ± 3.13*#
Note: compared to control group, *P < 0.05; compared to model group,
#P < 0.05.
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increasing of the drug dosage, showing signiﬁcant differences
between A, B and C group (P < 0.05), the results were shown in
Table 1.
3.2. Comparison of thymus and spleen indexes of mice
among ﬁve groups
The thymus and spleen index of mice in model group were
signiﬁcant higher than those of the other four groups (P < 0.05),
and the thymus and spleen index of treatment A and B group
were higher than control group and treatment C group
(P < 0.05). The thymus index of mice in treatment C group and
control group showed no signiﬁcant differences (P > 0.05), but
the spleen index of mice in treatment C group was higher than
that in control group (P < 0.05), the results were shown in
Table 2.
3.3. Comparison of splenic lymphocyte proliferation of
rays in ﬁve groups
The stimulation index of T and B lymphocytes of mice in
model group was signiﬁcant higher than that of the rest four
groups (P < 0.05). The stimulation index of T and B lympho-
cytes of mice in treatment A, B and C group decreased with the
increase of the drug dosage (P < 0.05), and the decrease level ofTable 2
Comparison of thymus and spleen indexes of mice in ﬁve groups (n = 10).
Groups Thymus Sp
Control group 0.09 ± 0.02# 0.06 ±
Model group 0.19 ± 0.03* 0.15 ±
Treatment A group 0.15 ± 0.03*# 0.13 ±
Treatment B group 0.13 ± 0.02*# 0.12 ±
Treatment C group 0.08 ± 0.02# 0.10 ±
Note: compared to control group, *P < 0.05; compared to model group, #P
Table 3
Comparison of the serum IFN-g, IL-4 and IL-10levels of mice among ﬁve g
Groups IFN-g
Control group 105.30 ± 22.10#
Model group 244.30 ± 42.68*
Treatment A group 192.60 ± 36.05*#
Treatment B group 187.40 ± 60.84*#
Treatment C group 150.40 ± 37.69*#
Note: compared to control group, *P < 0.05; compared to model group, #Pthe stimulation index of T lymphocytes in treatment B and C
group was higher than that of A group (P < 0.05);, the results
were shown in Table 2.
3.4. Comparison of the serum IFN-g, IL-4 and IL-10
levels of mice among ﬁve groups
The serum IFN-g level of mice in control group and treat-
ment A, B and C group was signiﬁcant lower than that of mice in
model group (P < 0.05);. The serum IFN-g level of mice in
treatment A, B and C group decreased with the increasing of the
drug dosage, and the level of C group was signiﬁcant lower than
that of A and B group (P < 0.05); the comparison of serum IL-4
and IL-10 of mice in model group and treatment A, B and C
showed no statistical differences (P > 0.05), and the results were
shown in Table 3.
4. Discussion
According to the epidemiologic investigation of the World
Allergic Organization (WAO) 250 million out of the 1200
million people have the allergic disease with different degrees
[10]. Another report shows that [11] about 35 million in USA have
suffered from hypersensitivity disease. And inhibiting the
hypersensitivity disease has become one of the hottest issues
in the world. The treatment of expenses of this disease in the
world has surpassed 8 billion dollars [12]. Therefore, the
prevention and cure of this disease becomes the burning issue
to be solved.
ACD, the common disease in dermatology, is a delayed type
hypersensitivity, which is the skin contact allergic reaction
mediated by antigen-speciﬁc T cells [13]. The incidence of ACD
is mainly on the contact sites, which can seriously cause the
erythema and the swelling and then induce the erosion and
scab of exudation [14]. In clinical treatment, the allergic source
should be ﬁrstly found out and keep the patients away from it.
If the allergic sources are conﬁrmed, the patch test can be
used for diagnosis. Drugs used to treat ACD mainly are the
glucocorticoid and the H1 receptor antagonists. And the H1
receptor antagonists have stronger effects on type I allergicleen T cells B cells
0.01# 0.82 ± 0.05# 1.00 ± 0.14#
0.01* 0.90 ± 0.12* 1.15 ± 0.22*
0.02*# 0.84 ± 0.11*# 1.13 ± 0.16*#
0.02*# 0.80 ± 0.09*# 1.05 ± 0.12*#
0.01*# 0.76 ± 0.06*# 0.97 ± 0.13*#
< 0.05.
roups (n = 10).
IL-4 IL-10
302.10 ± 13.20 209.15 ± 11.20
413.90 ± 66.73 353.20 ± 54.83
429.90 ± 48.81 373.10 ± 35.09
427.20 ± 30.11 367.10 ± 38.00
387.90 ± 38.11 369.80 ± 28.98
< 0.05.
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Patients with a serious ACD can be treated with the
glucocorticoid, which can effectively inhibit the type IV
allergic reaction in a short period. However, it will induce the
deﬁcient effects, such as infection, peptic ulcer and rarefaction
of bone that the patients can't tolerant [15–18]. Pseudolaric acid
is the new diterpenoid acid chemical compounds extracted
from dry root bark of pseudolarix raempferi gordon, which
can be used to treat tinea, and has insecticidal and anti-itch ef-
fects. Modern pharmacology conﬁrms that pseudolaric acid can
accelerate the proteasome to degrade the generation of the key
factor HIF-1 in new vessels, reduce the accumulation of the key
factor HIF-1, and has a remarkable anti-angiogenesis effects.
And another research shows that [8] pseudolaric acid has
effective role in ACD treatment, and it can adjust the
organism immune of patients effectively. In this study, the
weight gain of treatment A and B group were obviously lower
than that of control group (P < 0.05), but difference between
treatment C group and control group was not signiﬁcant
(P > 0.05) indicating that pseudolaric acid can inﬂuence the
weight of mice and improve the ill state of ACD. The
swelling degree and the quality of mice' ears in treatment A,
B, C groups were decreased with the increase of the drug
dosage, and the comparison between A, B and C group
showed statistically differences (P < 0.05), indicating that
pseudolaric acid can effectively treat the inﬂammatory lesions
of the ear skin of ACD mice.
T cells and B cells are the important lymphocytes in or-
ganism, which has the key effect on immune adjustment [19–23].
The stimulation index of T and B cells of mice in model group
was signiﬁcant higher than the other four groups (P < 0.05).
The stimulation index of T and B cells of mice in treatment
A, B and C group were decreased with the increase of the
drug dosage (P < 0.05), and the decrease level of the
stimulation index of T cells in treatment B and C group was
signiﬁcant higher than that of A group (P < 0.05), indicating
the concentration of 0.2%, 0.4% of pseudolaric acid has the
selective role of inhibiting the proliferation of T cells,
meanwhile the thymus and the spleen index of mice in
treatment A and B group were obviously higher than that of
mice in control group and treatment C group (P < 0.05). The
thymus index of mice in treatment C group and control
group showed no statistical differences (P > 0.05), but the
spleen index of mice in treatment C group was higher than
that in control group (P < 0.05). The serum IFN-g level of
mice in control group and treatment A, B and C group was
signiﬁcant lower than that of mice in model group
(P < 0.05). The serum IFN-g level of mice in control group
and treatment A, B and C group was decreased with the
increase of the drug dosage, and the level of C group was
obviously lower than that of A and B group (P < 0.05),
indicating that pseudolaric acid has the remarkable immune
adjustment function, which can inhibit the response of
immune system to itself and the external antigen and is
beneﬁt to the ACD treatment.
The results of this study show that the pseudolaric acid has
the effect of anti-inﬂammation and immune adjustment, which
has the remarkable treatment effect for the ACD mice.
Declare of interest statement
We declare that we have no conﬂict of interest.References
[1] Wang S, Yao X, Liu J. A case of lymphoma sample contact
dermatitis caused by diaminobenzene allergic reaction. Chin J
Dermatol 2015; 48(1): 62.
[2] Zhao XQ. Clinical analysis of 37 cases of paraquat induced contact
dermatitis. Chin J Dermatovenerol Integr Tradit West Med 2015;
14(1): 48-49.
[3] Yu X, Liu HL, Wang Y, Wang XY, Tao Y, Bao KF, et al.
Expression of IL-33 in different phases of allergic contact derma-
titis mouse model. Chin Pharmacol Bull 2015; 33(9): 1331-1332.
[4] Liu Y. The clinical curative effect of Kangfuxin liquid on treatment
of contact dermatitis. Chin J School Doctor 2015; 29(6): 447-450.
[5] Jiao XM. The intervention effect of health education on air source
contact dermatitis. Chin J Aesthetic Med 2015; 5(1): 160-161.
[6] Zhong S, Song ZQ. Update of the pathogenesis of contact
dermatitis. China J Lepr Skin Dis 2015; 31(1): 29-31.
[7] Han R. Etiology and exacerbation factors in facial dermatitis. Med
Aesthetic Cosmetol 2015; 24(6): 837.
[8] Sun Q, Li Y. [Antitumor effect and molecular mechanism of
pseudolaric acid B]. Chin J Integr Tradit West Med Dig 2014;
22(9): 551-555. Chinese.
[9] Yang Z, Zhang M, Wang YT, Zhang ML, Li T, Chen H. Discussion
of inhibiting effect and mechanism of the ramiﬁcation HPB of new
type of pseudolaric acid on T cells. Immunol J 2015; 31(7): 591-594.
[10] Huang JY, Ding DD, Li Y, Rong FJ, Zhang CL. Ostomy care
powder and is cured the contact clinical observation of dermatitis.
Stud Trace Elem Health 2015; 32(4): 16-17.
[11] Yao HW, Sheng RJ, Yang DL, Yan ZY, Sun XM. Investigation
and etiological analysis on an outbreak of occupational contact
dermatitis. Pract Prev Med 2015; 22(8): 955-958.
[12] Chen L. Observation of curative effect of daktarin powder com-
bined 0.02% potassium on contact dermatitis. Strait Pharm J 2015;
27(6): 231-232.
[13] Qian JL, Xu HJ, Zhao Y, Xun QM, Ma XL, Huang HY, et al.
Effect of benvitimod on allergic contact dermatitis in BALB/c
mice. Chin J Dermatol 2014; 47(9): 654-658.
[14] Hu Y, Sun Y, Li T, Chen XM, Zhang HQ, Yu AH, et al. Effects of
stimulating food on allergic contact dermatitis in mice model. Chin
J Dermatovenereol Integr Tradit West Med 2014; 13(2): 69-71.
[15] Bu P, Li YH, Zhu XF, Hu R. Effects of Yifu cream on allergic
contact dermatitis of mouse model. China J Lepr Skin Dis 2014;
30(11): 679-681.
[16] Liu WG, Ding HM. Clinical observation of Xiaoyin granules on
the treatment of allergic contact dermatitis. J Dermatol Venereol
2014; 36(1): 34.
[17] Hu YM, Ai RD, Zhong ZD, Zhu XY. The effect of purslane extract
on contact dermatitis in mice skin silk poly protein and cysteine
aspartic acid speciﬁc protease 14 protein expression. J Clin Der-
matol 2014; 43(2): 80-82.
[18] Dong YQ, Wang XM, Liu YQ, Wang TT, Zhang YW. In vitro tests
for allergic contact dermatitis. Int J Dermatol Venereol 2014;
40(6): 386-389.
[19] Wei N, Li T, Chen H, Mei X, Cao B, Zhang YY. The immuno-
suppressive activity of pseudolaric acid B on T lymphocytes
in vitro. Phytother Res 2013; 27(7): 980-985.
[20] Li T, Chen H, Yang Z. Topical application of pseudolaric acid B
improve DNFB -induced contact hypersensitivity via regulating the
balance of Th1/Th17/Treg cell subsets. Eur J Pharm Sci 2012;
45(5): 668-676.
[21] Li T, Wang H, Chen H, Liu X, Yang JN, Cao B, et al. The pre-
liminary study of pseudolaric acid B on speciﬁc immune response.
Chin Pharmacol Bull 2013; 29(2): 421-425.
[22] Tang Q, Zou P, Jin H, Fu J, Yang J, Shang L, et al. Grape-seed
proanthocyanidins ameliorate contact hypersensitivity induced by
2,4-dinitroﬂuorobenzene (DNFB) and inhibit T cell proliferation
in vitro. Toxicol Lett 2012; 210(1): 1-8.
[23] Panda BB, Achary VM. Mitogen-activated protein kinase signal
transduction and DNA repair network are involved in aluminum-
induced DNA damage and adaptive response in root cells of
Allium cepa L. Front Plant Sci 2014; 5(6): 256.
